Cerebrovascular Risk Factors, Vascular Disease, and Neuropsychological Outcomes in Adults With Major Depression
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Objective: To investigate the relationship of cerebrovascular risk factors (CVRFs), endothelial function, carotid artery intima medial thickness (IMT), and neuropsychological performance in a sample of 198 middle-aged and older individuals with major depressive disorder (MDD). Neuropsychological deficits are common among adults with MDD, particularly among those with CVRFs and potentially persons with subclinical vascular disease. Methods: CVRFs were indexed by the Framingham Stroke Risk Profile (FSRP) and serum cholesterol levels obtained by medical history and physical examination. Patients completed a neuropsychological test battery including measures of executive functioning, working memory, and verbal recall. Vascular function was indexed by carotid artery IMT and brachial artery flow mediated dilation (FMD). Hierarchical multiple regression analyses were used to investigate the association between CVRFs, vascular disease, and neurocognitive performance. Results: Greater FSRP scores were associated with poorer executive functioning (b = −0.86; p = .041) and working memory (b = −0.90; p = .024). Lower high-density lipoprotein levels also were associated with poorer executive functioning (b = 1.03; p = .035). Higher IMT (b = −0.83; p = .028) and lower FMD (b = 1.29; p = .032) were associated with poorer executive functioning after controlling for CVRFs. Lower FMD was also associated with poorer working memory (b = 1.58; p = .015). Conclusions: Greater CVRFs were associated with poorer neuropsychological performance. Vascular dysfunction also was associated with neuropsychological decrements independent of traditional CVRFs. CVRF = cerebrovascular risk factor; FSRP = Framingham Stroke Risk Profile; MDD = major depressive disorder; IMT = intima medial thickness; GTN = glyceryl trinitrate; GTN-D = glyceryl trinitrate dilation; FMD = flow mediated dilation; HDL = high-density lipoprotein; LDL = low-density lipoprotein; Ham-D = Hamilton Rating Scale for Depression; DSST = digit symbol substitution test; COWAT = controlled oral word association test; DST = digit span test; CHD = coronary heart disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wilamowska (2010) · doi:10.1001/archpsyc.1988.01800320058007 · Cited by 2,115
'Vascular Depression' Hypothesis
Alexopoulos, G. S. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830220033006 · Cited by 1,843 · cited 3×
“Furthermore, CVRFs have been associated with an increased risk for the development of mild cognitive impairment (16), a variety of neuroanatomical abnormalities (17–20), and an increased incidence of vascular depression (21).”
BackgroundProbability of stroke: a risk profile from the Framingham Study.
Wolf, P. A., D'Agostino, R. B., Belanger, A. J., & Kannel, W. B. (1991) · Stroke · doi:10.1161/01.str.22.3.312 · Cited by 1,782 · cited 1×
“Risk factors used to assess stroke risk include systolic blood pressure, use of antihypertensive therapy, diabetes mellitus, cigarette smoking, cardiovascular disease, and atrial fibrillation (31,32).”
BackgroundCognitive deficits in depression: Possible implications for functional neuropathology
Austin, M.-P., Mitchell, P., & Goodwin, G. M. (2001) · British Journal of Psychiatry · doi:10.1192/bjp.178.3.200 · Cited by 1,154
Depression: Perspectives from Affective Neuroscience
Davidson, R. J., Pizzagalli, D., Nitschke, J. B., & Putnam, K. (2002) · Annual Review of Psychology · doi:10.1146/annurev.psych.53.100901.135148 · Cited by 1,138
Cardiovascular risk factors and cognitive decline in middle-aged adults
Knopman, D., Boland, L. L., Mosley, T., Howard, G., Liao, D., Szklo, M., McGovern, P., & Folsom, A. R. (2001) · Neurology · doi:10.1212/wnl.56.1.42 · Cited by 883 · cited 3×
“Previous population studies have shown that greater levels of CVRFs may be associated with a poorer cognitive functioning (44).”
BackgroundVascular risk factors for Alzheimer’s disease:
Breteler, M. M. B. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(99)00110-4 · Cited by 664
White matter lesions impair frontal lobe function regardless of their location
Tullberg, M., Fletcher, E., DeCarli, C., Mungas, D., Reed, B. R., Harvey, D. J., Weiner, M. W., Chui, H. C., & Jagust, W. J. (2004) · Neurology · doi:10.1212/01.wnl.0000130530.55104.b5 · Cited by 530
Neurocognitive impairment in drug-free patients with major depressive disorder
Porter, R. J., Gallagher, P., Thompson, J. M., & Young, A. H. (2003) · British Journal of Psychiatry · doi:10.1192/bjp.182.3.214 · Cited by 519
Attention and executive functions in remitted major depression patients
Paelecke-Habermann, Y., Pohl, J., & Leplow, B. (2005) · Journal of Affective Disorders · doi:10.1016/j.jad.2005.09.006 · Cited by 487
Cited by
Smith, P. J., Blumenthal, J. A., Hoffman, B. M., Cooper, H., Strauman, T. A., Welsh-Bohmer, K., Browndyke, J. N., & Sherwood, A. (2010) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3181d14633 · Cited by 1,714
Self-citationRelations of arterial stiffness and endothelial function to brain aging in the community
Tsao, C. W., Seshadri, S., Beiser, A. S., Westwood, A. J., DeCarli, C., Au, R., Himali, J. J., Hamburg, N. M., Vita, J. A., Levy, D., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e3182a43e1c · Cited by 253
Neurocognitive changes after lung transplantation
Smith, P. J., Rivelli, S., Waters, A., Reynolds, J., Hoyle, A., Flowers, M., Davis, R. D., Palmer, S. M., Mathew, J., Durheim, M., et al. (2014) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201406-232oc · Cited by 60
Self-citationDelirium affects length of hospital stay after lung transplantation
Smith, P. J., Rivelli, S. K., Waters, A. M., Hoyle, A., Durheim, M. T., Reynolds, J. M., Flowers, M., Davis, R. D., Palmer, S. M., Mathew, J. P., et al. (2015) · Journal of Critical Care · doi:10.1016/j.jcrc.2014.09.010 · Cited by 49
“For example, underlying cerebrovascular disease and neuronal dysfunction may have been associated with worse pretransplant cognitive function and posttransplant delirium [10,31-33], whereas modifiable factors, including fatigue and shortness of breath,may have been associated with poorer cognitive performance but woul…”
BackgroundSelf-citationVascular growth factors in neuropsychiatry
Newton, S. S., Fournier, N. M., & Duman, R. S. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1281-9 · Cited by 48
“Increasing evidence suggests that vascular dysfunction plays a critical role in the etiology of depression [75–78].”
Background
Metadata
- Authors
- Smith, P. J., Blumenthal, J. A., Babyak, M. A., Hoffman, B. M., Doraiswamy, P. M., Waugh, R., Hinderliter, A., & Sherwood, A.
- Venue
- Psychosomatic Medicine
- Published
- 2007-07
- Volume
- 69
- Issue
- 6
- Pages
- 578-586
- ISSN
- 0033-3174 (ISSN-L)
- OpenAlex
- W1992235145
- Cited by
- 53
- References
- 16
- FWCI
- 3.02
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cerebrovascular Risk Factors, Vascular Disease, and Neuropsychological Outcomes in Adults With Major Depression. https://app.cochat.ai/papers/10.1097/psy.0b013e31812f7b8e
- The paper
- Smith, P. J., Blumenthal, J. A., Babyak, M. A., Hoffman, B. M., Doraiswamy, P. M., Waugh, R., Hinderliter, A., & Sherwood, A. (2007). Cerebrovascular Risk Factors, Vascular Disease, and Neuropsychological Outcomes in Adults With Major Depression. Psychosomatic Medicine. https://doi.org/10.1097/psy.0b013e31812f7b8e
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.